Dyne Therapeutics (NASDAQ:DYN) Now Covered by Raymond James
Raymond James assumed coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a research report issued on Wednesday, MarketBeat.com reports. The firm set an “outperform” rating and a $37.00 price target on the stock. Raymond James’ target price points to a potential upside of 155.88% from the company’s current price. Other equities […]
Raymond James assumed coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a research report issued on Wednesday, MarketBeat.com reports. The firm set an “outperform” rating and a $37.00 price target on the stock. Raymond James’ target price points to a potential upside of 155.88% from the company’s current price. Other equities […]
